01.05: Structure-Based Drug Design

Invited Abstracts

217A

Wednesday, May 29




08:00 - 08:30 AM 01.05.01A
(E0052)
Cele Abad-Zapatero.
Advances in the Structure- based Drug Design of Potent and Selective hPTB1B Inhibitors for the Treatment of Type II Diabetes.
et al: B. Szczepankiewicz, Z. Pierce, Z. Xin, H. Zhao, C. Hutchins, P. Hajduk, S. Ballaron, M. Stashko, T. Lubben Et Al.

08:30 - 09:00 AM 01.05.01
(W0279)
R. Scott Rowland.
Application of Structure- Based Drug Design in Drug Discovery and Development.

09:00 - 09:30 AM 01.05.02
(W0320)
Rachel A. Powers.
Structure- Based Discovery of a Novel, Non-Covalent Inhibitor of AmpC beta-lactamase.
et al: Federica Morandi, Brian K. Shoichet.

09:30 - 10:00 AM 01.05.03
(W0374)
Ernst Ter Haar.
Crystal Structures of GSK3b a Potential Target for Type 2 Diabetes Therapy.
et al: Joyce Coll, Richard Petrillo, Ted Fox, Douglas Austen, Hsun-Mei Hsiao, Lora Swenson.

10:00 - 10:30 AM
Coffee Break.

10:30 - 11:00 AM 01.05.04
(W0295)
Lisa Shewchuk.
Design of Cdk2 Inhibitors for Prevention of Chemotherapy- Induced Alopecia.

11:00 - 11:30 AM 01.05.05
(W0110)
Stanley M. Swanson.
Adding a Dimension to Molecular Docking: Force Feedback.
et al: Jennifer S. Novak, Shahram Khademi, Edgar F. Meyer.

11:30 - 12:00 AM 01.05.06
(W0375)
Corey Strickland.
Structural Studies of Farnesyl Protein Transferase Inhibitors.
et al: Linda Syto, William Windsor, Patricia Weber.


Contact: aca-inquiries@hwi.buffalo.edu

Last updated: Tue Apr 30 21:59:27 EDT 2002


WG
WebGlimpse
Search Options
Search: The neighborhood of this page The full archive